Skip to main content

Table 3 The genotype frequencies of MMP polymorphisms according to age of participants

From: The GC + CC genotype at position -418 in TIMP-2 promoter and the -1575GA/-1306CC genotype in MMP-2is genetic predisposing factors for prevalence of moyamoya disease

 

Age <18

Age <18

Characteristic

Control (n = 102)

Moyamoya (n = 56)

AOR (95% CI)

P a

P b

Control (n = 141)

Moyamoya (n = 51)

AOR (95% CI)

P a

P b

MMP-2 -1575G > A

          

GG

88 (86.3)

46 (82.1)

1.00 (reference)

  

122 (86.5)

46 (90.2)

1.00 (reference)

  

GA

14 (13.7)

10 (17.9)

1.32 (0.54-3.23)

0.55

0.55

19 (13.5)

5 (9.8)

0.73 (0.26-2.08)

0.56

0.56

AA

0 (0.0)

0 (0.0)

NA

NA

 

0 (0.0)

0 (0.0)

NA

NA

 

Dominant (GG vs. GA + AA)

 

1.32 (0.54-3.23)

0.55

0.55

  

0.73 (0.26-2.08)

0.56

0.56

Recessive (GG + GA vs. AA)

 

NA

NA

   

NA

NA

 

MMP-2 -1306C > T

          

CC

90 (88.2)

53 (94.6)

1.00 (reference)

  

132 (93.6)

46 (90.2)

1.00 (reference)

  

CT

12 (11.8)

3 (5.4)

0.44 (0.12-1.65)

0.22

0.22

9 (6.4)

5 (9.8)

1.63 (0.51-5.17)

0.41

0.41

TT

0 (0.0)

0 (0.0)

NA

NA

 

0 (0.0)

0 (0.0)

NA

NA

 

Dominant (CC vs. CT + TT)

 

0.44 (0.12-1.65)

0.22

0.22

  

1.63 (0.51-5.17)

0.41

0.41

Recessive (CC + CT vs. TT)

 

NA

NA

   

NA

NA

 

MMP-3 -1171 5a/6a

          

6a6a

76 (74.5)

43 (76.8)

1.000 (reference)

  

111 (78.7)

35 (68.6)

1.00 (reference)

  

6a5a

24 (23.5)

10 (17.9)

0.73 (0.32-1.69)

0.46

0.61

27 (19.1)

13 (25.5)

1.52 (0.71-3.27)

0.28

0.28

5a5a

2 (2.0)

3 (5.4)

3.03 (0.47-19.31)

0.24

0.48

3 (2.1)

3 (5.9)

3.17 (0.61-16.45)

0.17

0.28

Dominant (6a6a vs. 6a5a + 5a5a)

 

0.90 (0.42-1.95)

0.80

0.80

  

1.69 (0.82-3.46)

0.15

0.28

Recessive (6a6a + 6a5a vs. 5a5a)

 

3.55 (0.56-22.60)

0.18

0.48

  

2.89 (0.56-14.94)

0.21

0.28

MMP-9 -1562C > T

          

CC

79 (77.5)

45 (80.4)

1.00 (reference)

  

116 (82.3)

40 (78.4)

1.00 (reference)

  

CT

22 (21.6)

9 (16.1)

0.62 (0.257-1.493)

0.29

0.39

25 (17.7)

10 (19.6)

1.22 (0.54-2.79)

0.63

0.63

TT

1 (1.0)

2 (3.6)

3.79 (0.33-43.80)

0.29

0.39

0 (0.0)

1 (2.0)

NA

NA

 

Dominant (CC vs. CT + TT)

 

0.75 (0.33-1.71)

0.49

0.49

  

1.34 (0.60-3.00)

0.47

0.63

Recessive (CC + CT vs. TT)

 

4.24 (0.37-48.86)

0.25

0.39

  

NA

NA

 

MMP-9 Q279R

          

GG

41 (40.2)

29 (51.8)

1.000 (reference)

  

59 (41.8)

27 (52.9)

1.00 (reference)

  

GA

52 (51.0)

25 (44.6)

0.70 (0.35-1.38)

0.30

0.30

68 (48.2)

21 (41.2)

0.65 (0.33-1.29)

0.22

0.29

AA

9 (8.8)

2 (3.6)

0.25 (0.05-1.29)

0.10

0.30

14 (9.9)

3 (5.9)

0.41 (0.10-1.60)

0.20

0.29

Dominant (GG vs. GA + AA)

 

0.63 (0.32-1.24)

0.19

0.30

  

0.62 (0.32-1.18)

0.15

0.29

Recessive (GG + GA vs. AA)

 

0.38 (0.08-1.83)

0.23

0.30

  

0.52 (0.14-1.92)

0.33

0.33

  1. Adjusted by age and gender. NA; Not applicable.
  2. a P value obtained by Fisher's exact test.
  3. bFalse positive discovery rate-adjusted P value.